Financials
Financial year 2025
Dr. E. Macken from Hasselt, company number BE0668791145, closed financial year 2025 with a result of € 601,320 after tax. For that financial year Dr. E. Macken recorded a gross margin of € 784,613 and equity of € 324,328. Compared with financial year 2024, the result moved from € 572,708 to € 601,320. Profitable, and profit is growing. The buffer shrank hard: equity is 68 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 324,328
▼ 68% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 601,320
▲ 5% vs 2024
Profit after tax over the fiscal year.
€ 1.1 million
▲ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.3 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 483
▼ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,093
▲ 274% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 140,145
▲ 23% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 660,257 | € 613,205 | € 731,703 | € 784,613 | ▲ 7% |
| Profit after taxes | € 504,318 | € 466,252 | € 572,708 | € 601,320 | ▲ 5% |
| Equity | € 1,212,081 | € 978,333 | € 1,021,041 | € 324,328 | ▼ 68% |
| Total debts | € 567,057 | € 748,612 | € 903,584 | € 1,219,300 | ▲ 35% |
| Cash | € 1,008,605 | € 312,247 | € 756,046 | € 1,135,036 | ▲ 50% |
| Retained profit | € 1,193,481 | € 959,733 | € 1,002,441 | € 305,728 | ▼ 70% |
| Dividend | € 482,000 | € 700,000 | € 530,000 | € 1,298,033 | ▲ 145% |
| Bank debt | € 48,119 | € 19,282 | € 0 | € 0 | |
| Balance sheet total | € 1,779,138 | € 1,726,945 | € 1,924,625 | € 1,543,628 | ▼ 20% |
Key figures of Dr. E. Macken, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. E. Macken?
What happened at Dr. E. Macken in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 601,320 (▲ 5% vs 2024). Source: NBB ↗
- New establishment in Zonhoven. KBO
- ELINE MACKEN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 504,318 profit in 2022 to € 601,320 profit in 2025.
Paid € 698,527 in corporate taxes since 2022.
Best year ever: 2025, with € 601,320 profit.
Paid out € 3 million in dividends to the owners in total.
Management
Behind Dr. E. Macken is ELINE MACKEN. It owns 16.7% of NEFROZOL cvba itself.
Directors
According to the 2025 annual accounts
ELINE MACKEN
Director
since 2017
Establishments
Establishment units
Physical locations of this company
Casterstraat 70 box bus 1
3500 Hasselt
Kriekelstraat 81
3520 Zonhoven
Active since 5 January 2017
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0668.791.145
- VAT number
- BE 0668.791.145
- Registered office
- Casterstraat 70 bus bus 1, 3500 Hasselt
- Names & denominations
- Dr. E. Macken
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 January 2017
- Peppol
- Active · Active since 28 Jul 2024